Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 233–240 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Aldeyra Therapeutics Inc. Ganetespib (ADX-1612) Ovarian cancer Phase 2 Intravenous Oncology
Aldeyra Therapeutics Inc. Ganetespib (ADX-1612) Post-transplant lymphoproliferative disorder Phase 2 Intravenous Oncology
Aldeyra Therapeutics Inc. Reproxalap (ADX-102) - (TRANQUILITY-2) Dry eye disease Phase 3 Ocular Opthalmic
Aldeyra Therapeutics Inc. Ganetespib (ADX-1612) Post-transplant lymphoproliferative disorder Phase 2 Intravenous Oncology
Aldeyra Therapeutics Inc. ADX-629 Moderate / Acute Alcoholic Hepatitis Phase 2 Trial Discontinued Oral Gastroenterology
Aldeyra Therapeutics Inc. Reproxalap (ADX-102) Sjögren-Larsson Syndrome (SLS) Phase 3 Ophthalmic Genetic Disorder
Aldeyra Therapeutics Inc. Reproxalap - (Crossover study) Dry eye disease Phase 3 Ophthalmic Opthalmic
Aldeyra Therapeutics Inc. Reproxalap (ADX-102) - (INVIGORATE-2) Allergic conjunctivitis NDA Filing Data Released Ophthalmic Opthalmic